Document Type

Journal Article

Publication Title

Journal of Alzheimer's Disease Reports

Volume

8

Issue

1

First Page

1009

Last Page

1021

Publisher

IOS Press

School

School of Medical and Health Sciences

Funders

Macquarie University / Australian Alzheimer's Research Foundation / Lions Alzheimer's Foundation

Comments

De Guia, I. L., Eslick, S., Naismith, S. L., Kanduri, S., Shah, T. M., & Martins, R. N. (2024). The crosstalk between amyloid-β, retina, and sleep for the early diagnosis of Alzheimer’s disease: A narrative review. Journal of Alzheimer's Disease Reports, 8(1), 1009-1021. https://doi.org/10.3233/ADR-230150

Abstract

Alzheimer's disease (AD) is the most common type of dementia, which is characterised by progressive memory loss and accumulation of hallmark markers amyloid-β (Aβ) and neurofibrillary tangles in the diseased brain. The current gold standard diagnostic methods have limitations of being invasive, costly, and not easily accessible. Thus, there is a need for new avenues, such as imaging the retina for early AD diagnosis. Sleep disruption is symptomatically frequent across preclinical and AD subjects. As circadian activity, such as the sleep-wake cycle, is linked to the retina, analysis of their association may be useful additions for achieving predictive AD diagnosis. In this narrative review, we provide an overview of human retina studies concerning the deposition of Aβ, the role of the retina in sleep-wake cycle, the disruption of sleep in AD, and to gather evidence for the associations between Aβ, the retina, and sleep. Understanding the mechanisms behind the associations between Aβ, retina, and sleep could assist in the interpretation of retinal changes accurately in AD.

DOI

10.3233/ADR-230150

Creative Commons License

Creative Commons Attribution-Noncommercial 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License

Included in

Neurosciences Commons

Share

 
COinS